PentaBind is a VC-backed drug discovery company using Artificial Intelligence and an integrated wet-laboratory to design high performance aptamers with multiple drug-like qualities in one step. They develop their own pipeline therapeutic assets with aptamers as an active ingredient and aptamers as a delivery vehicle.
Shortlisted as New Startup of the Year by Cancer Research Horizons.
PentaBind is is supported by Entrepreneur First VC, Twin Path, P4SY, Panacea Stars, Stevenage Bioscience Catalyst, Science Creates Accelerator, Science Entrepreneur Club, and KQ Labs (the Francis Crick Institute).
For more information or to join our mission: contact@PentaBind.com
***We are hiring Computational Biologists, Molecular Biologists, Protein and Data Engineers. Don't hesitate to reach out!***
Company Details
- Employees
- 11
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pentabind.com/
- Keywords
- London.
- HQ
- London
Pentabind Questions
Pentabind's website is https://www.pentabind.com/
Pentabind's LinkedIn profile is https://uk.linkedin.com/company/pentabind
Pentabind has
11 employees.
View email and phone details for 11
employees at Pentabind.
Pentabind's industry is
Biotechnology Research
Pentabind's top competitors are
Isomorphic Labs,
Pear Bio,
Kq Labs,
Octiocor,
The Francis Crick Institute,
Stevenage Bioscience Catalyst,
Arctoris,
Plurify,
Relation,
Labgenius Therapeutics.
Pentabind's categories are Biotechnology Research
Pentabind's founding year is 2021
